Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ZNF513 antibody (AA 1-300)

ZNF513 Reactivity: Human ELISA, IHC Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7176351
  • Target See all ZNF513 Antibodies
    ZNF513 (Zinc Finger Protein 513 (ZNF513))
    Binding Specificity
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-300
    Reactivity
    • 11
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    Human
    Host
    • 11
    Rabbit
    Clonality
    • 11
    Polyclonal
    Conjugate
    • 7
    • 2
    • 1
    • 1
    This ZNF513 antibody is un-conjugated
    Application
    ELISA, Immunohistochemistry (IHC)
    Cross-Reactivity
    Human
    Purification
    >95%, Protein G purified
    Immunogen
    Recombinant Human Zinc finger protein 513 protein (1-300AA)
    Isotype
    IgG
  • Application Notes
    Recommended dilution: IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    ZNF513 (Zinc Finger Protein 513 (ZNF513))
    Alternative Name
    ZNF513 (ZNF513 Products)
    Synonyms
    cb557 antibody, sb:cb557 antibody, si:ch211-101l18.1 antibody, si:ch211-278j3.2 antibody, HMFT0656 antibody, RP58 antibody, AW990386 antibody, D430028M17Rik antibody, Znf513 antibody, zinc finger protein 513a antibody, zinc finger protein 513 antibody, znf513a antibody, ZNF513 antibody, Zfp513 antibody
    Background

    Background: Transcriptional regulator that plays a role in retinal development and maintenance.

    Aliases: ZNF513 antibody, Zinc finger protein 513 antibody

    UniProt
    Q8N8E2
You are here: